Pre-Clinical Evaluation of a Replication-Competent Recombinant Adenovirus Serotype 4 Vaccine Expressing Influenza H5 Hemagglutinin

• Jeff Alexander ,

  * E-mail: jalexander@paxvax.com

  Affiliation PaxVax Inc., San Diego, California, United States of America

  ⨯
• Simone Ward,

  Current address: The Scripps Research Institute, La Jolla, California, United States of America

  Affiliation PaxVax Inc., San Diego, California, United States of America

  ⨯
• Jason Mendy,

  Affiliation PaxVax Inc., San Diego, California, United States of America

  ⨯
• Darly J. Manayani,

  Affiliation PaxVax Inc., San Diego, California, United States of America

  ⨯
• Peggy Farness,

  Affiliation PaxVax Inc., San Diego, California, United States of America

  ⨯
• Jenny B. Avanzini,

  Affiliation PaxVax Inc., San Diego, California, United States of America

  ⨯
• Ben Guenther,

  Affiliation PaxVax Inc., San Diego, California, United States of America

  ⨯
• Fermin Garduno,

  Affiliation PaxVax Inc., San Diego, California, United States of America

  ⨯
• Lily Jow,

  Affiliation PaxVax Inc., San Diego, California, United States of America

  ⨯
• Victoria Snarsky,

  Affiliation PaxVax Inc., San Diego, California, United States of America

  ⨯
• Glenn Ishioka,

  Affiliation PaxVax Inc., San Diego, California, United States of America

  ⨯
• Xin Dong,

  Current address: Neostasis, Inc., San Diego, California, United States of America

  Affiliation PaxVax Inc., San Diego, California, United States of America

  ⨯
• Lo Vang,

  Affiliation PaxVax Inc., San Diego, California, United States of America

  ⨯
• Mark J. Newman,

  Current address: GeoVax Inc., Smyrna, Georgia, United States of America

  Affiliation PaxVax Inc., San Diego, California, United States of America

  ⨯
• Tim Mayall

  Affiliation PaxVax Inc., San Diego, California, United States of America

  ⨯